Literature DB >> 23774112

Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.

Anna Thora Grimsrud1, Morna Cornell, Matthias Egger, Andrew Boulle, Landon Myer.   

Abstract

OBJECTIVE: To examine the impact of different definitions of loss to follow-up (LTFU) on estimates of program outcomes in cohort studies of patients on antiretroviral therapy (ART). STUDY DESIGN AND
SETTING: We examined the impact of different definitions of LTFU using data from the International Epidemiological Databases to Evaluate AIDS-Southern Africa. The reference approach, Definition A, was compared with five alternative scenarios that differed in eligibility for analysis and the date assigned to the LTFU outcome. Kaplan-Meier estimates of LTFU were calculated up to 2 years after starting ART.
RESULTS: Estimated cumulative LTFU were 14% and 22% at 12 and 24 months, respectively, using the reference approach. Differences in the proportion LTFU were reported in the alternative scenarios with 12-month estimates of LTFU varying by up to 39% compared with Definition A. Differences were largest when the date assigned to the LTFU outcome was 6 months after the date of last contact and when the site-specific definition of LTFU was used.
CONCLUSION: Variation in the definitions of LTFU within cohort analyses can have an appreciable impact on estimated proportions of LTFU over 2 years of follow-up. Use of a standardized definition of LTFU is needed to accurately measure program effectiveness and comparability between programs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiretroviral therapy; Cohort; Loss to follow-up; Program outcomes; Retention; Survival analysis

Mesh:

Substances:

Year:  2013        PMID: 23774112      PMCID: PMC3759810          DOI: 10.1016/j.jclinepi.2013.03.013

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  36 in total

1.  Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition.

Authors:  Anna Grimsrud; Nathan Ford; Landon Myer
Journal:  Trop Med Int Health       Date:  2010-12-08       Impact factor: 2.622

2.  Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Authors:  Matthias Egger; Didier K Ekouevi; Carolyn Williams; Rita Elias Lyamuya; Henri Mukumbi; Paula Braitstein; Tyler Hartwell; Claire Graber; Benjamin H Chi; Andrew Boulle; François Dabis; Kara Wools-Kaloustian
Journal:  Int J Epidemiol       Date:  2011-05-18       Impact factor: 7.196

3.  Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.

Authors:  Morna Cornell; Anna Grimsrud; Lara Fairall; Matthew P Fox; Gilles van Cutsem; Janet Giddy; Robin Wood; Hans Prozesky; Lerato Mohapi; Claire Graber; Matthias Egger; Andrew Boulle; Landon Myer
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

4.  Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.

Authors:  Kate Clouse; Audrey Pettifor; Mhairi Maskew; Jean Bassett; Annelies Van Rie; Cynthia Gay; Frieda Behets; Ian Sanne; Matthew P Fox
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

Review 5.  Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review.

Authors:  Katharina Kranzer; Nathan Ford
Journal:  Trop Med Int Health       Date:  2011-07-01       Impact factor: 2.622

6.  Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors.

Authors:  Katharina Kranzer; James J Lewis; Nathan Ford; Jennifer Zeinecker; Catherine Orrell; Stephen D Lawn; Linda-Gail Bekker; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

7.  Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.

Authors:  Gilles Van Cutsem; Nathan Ford; Katherine Hildebrand; Eric Goemaere; Shaheed Mathee; Musaed Abrahams; David Coetzee; Andrew Boulle
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

8.  Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.

Authors:  Benjamin H Chi; Constantin T Yiannoutsos; Andrew O Westfall; Jamie E Newman; Jialun Zhou; Carina Cesar; Martin W G Brinkhof; Albert Mwango; Eric Balestre; Gabriela Carriquiry; Thira Sirisanthana; Henri Mukumbi; Jeffrey N Martin; Anna Grimsrud; Melanie Bacon; Rodolphe Thiebaut
Journal:  PLoS Med       Date:  2011-10-25       Impact factor: 11.069

9.  Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Authors:  Franziska Schöni-Affolter; Olivia Keiser; Albert Mwango; Jeffrey Stringer; Bruno Ledergerber; Lloyd Mulenga; Heiner C Bucher; Andrew O Westfall; Alexandra Calmy; Andrew Boulle; Namwinga Chintu; Matthias Egger; Benjamin H Chi
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

10.  Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.

Authors:  Edward J Mills; Christine Nabiryo
Journal:  PLoS Med       Date:  2013-01-08       Impact factor: 11.069

View more
  39 in total

Review 1.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 2.  Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations.

Authors:  Maya Petersen; Constantin T Yiannoutsos; Amy Justice; Matthias Egger
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

3.  Understanding data sources to measure patient retention in HIV care in sub-Saharan Africa.

Authors:  Kate Clouse; Tamsin Phillips; Landon Myer
Journal:  Int Health       Date:  2017-07-01       Impact factor: 2.473

4.  Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.

Authors:  Morna Cornell; Leigh F Johnson; Michael Schomaker; Frank Tanser; Mhairi Maskew; Robin Wood; Hans Prozesky; Janet Giddy; Kathryn Stinson; Matthias Egger; Andrew Boulle; Landon Myer
Journal:  Lancet HIV       Date:  2015-08-04       Impact factor: 12.767

5.  Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.

Authors:  Meridith Blevins; Eurico José; Fernandes R Bilhete; Lara M E Vaz; Bryan E Shepherd; Carolyn M Audet; Sten H Vermund; Troy D Moon
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

6.  Use of big data to identify risk of adverse HIV outcomes.

Authors:  Sten H Vermund
Journal:  Lancet HIV       Date:  2019-07-11       Impact factor: 12.767

7.  Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013.

Authors:  Nicole L De La Mata; Penh S Ly; Kinh V Nguyen; Tuti P Merati; Thuy T Pham; Man P Lee; Jun Y Choi; Jeremy Ross; Matthew G Law; Oon T Ng
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

8.  Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Anthony Obeid; Xinxiao Gao; Ferhina S Ali; Christopher M Aderman; Abtin Shahlaee; Murtaza K Adam; Sundeep K Kasi; Leslie Hyman; Allen C Ho; Jason Hsu
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

9.  Implementation and Operational Research: Decentralization Does Not Assure Optimal Delivery of PMTCT and HIV-Exposed Infant Services in a Low Prevalence Setting.

Authors:  Andrew Edmonds; Lydia Feinstein; Vitus Okitolonda; Deidre Thompson; Bienvenu Kawende; Frieda Behets
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

10.  CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.

Authors:  Anna Grimsrud; Morna Cornell; Michael Schomaker; Matthew P Fox; Catherine Orrell; Hans Prozesky; Kathryn Stinson; Frank Tanser; Matthias Egger; Landon Myer
Journal:  J Epidemiol Community Health       Date:  2015-12-23       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.